Investors & Media Company Profile

A ProQRian working on a cell culture in the laboratory

Located in Leiden, Netherlands and Cambridge, Mass., ProQR Therapeutics (Nasdaq:PRQR) is a biotechnology company dedicated to changing lives through the creation of transformative RNA therapies. ProQR is pioneering a next-generation RNA technology called Axiomer®, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind.


A list of past and future conferences and events

Where to meet us

events icon

Financial information

Latest SEC filings, annual reports and AGM documents

View details

Financial information icon

Presentations and publications

The latest scientific publications for our development programs

View scientific publications

presentations and publications icon

Corporate governance

Documents related to corporate governance

Go to documents

corporate governance icon


A list of the analysts that cover ProQR

See the list

analysts icon

ProQR Share Performance